Q Chip successfully reports preclinical studies with therapeutic cancer peptides
25-Feb-2011 -
Q Chip Ltd announced it has successfully completed preclinical studies with formulations of two leading therapeutic cancer peptides. The peptides, Q-Leuprolide and Q-Octreotide for prostate cancer and acromegaly respectively, were formulated using Q Chip’s innovative drug delivery platform, ...
cancer
Leuprolide
Octreotide
+1